What did EBOS Group Limited announce?

EBOS Group Limited (NZX: EBO) filed “Prime100 Media Speculation” with NZX on 15 July 2024, as an NZX announcement.

From the announcement:“EBOS advises it will not be participating in any potential forthcoming sale of Prime100. Authorised for lodgement with NZX and ASX by: Janelle Cain General Counsel EBOS Group Limited +61 3 9918 5555 About EBOS Group EBOS Group Limited NZBN 9429031998840 (NZX/ASX Code: EBO) is the largest and most diversified Australasian marketer, wholesaler and distributor of healthcare, medical and pharmaceutical products.”
When was it filed?
15 July 2024
Where is the original?
NZX announcement
EBOS Group Limited/Announcement
EBOS Group Limited logo

Prime100 Media Speculation

General15 July 2024EBOHealthcare

EBOS Group Limited. NZBN 9429031998840
108 Wrights Road, Addington, Christchurch, New Zealand, 8024

Level 7, 737 Bourke Street, Docklands, Victoria, Australia, 3008

Phone: +61 3 9918 5555, Fax: +61 3 9918 5588.

www.ebosgroup.com



16 July 2024



NZX/ASX Code: EBO



EBOS and Prime100 Media Speculation


EBOS Group Limited (“EBOS”) notes media commentary (Financial Review – Street Talk, 15 July 2024)

speculating on EBOS’ interest in the potential sale of pet food business Prime100.


EBOS advises it will not be participating in any potential forthcoming sale of Prime100.




Authorised for lodgement with NZX and ASX by:

Janelle Cain

General Counsel

EBOS Group Limited

+61 3 9918 5555








About EBOS Group

EBOS Group Limited NZBN 9429031998840 (NZX/ASX Code: EBO) is the largest and most diversified

Australasian marketer, wholesaler and distributor of healthcare, medical and pharmaceutical

products. It is also a leading Australasian animal care brand owner, product marketer and distributor.

Data sourced from publicly available filings. Our datasets may not be complete. Automated analysis can produce errors. If you believe any data on this page is incorrect, please contact us at hello@nzxplorer.co.nz. For informational purposes only. Not investment advice.